Scopus BioPharma share price logo

Scopus BioPharma

OTC: SCPS

$0.00

Live

as on

Scopus BioPharma Stock Performance

as on October 16, 2026 at 2:11 am IST

  • Day's Low

    Day's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Scopus BioPharma share price movements today

Previous Close
$0.00
Open
-
Volume
150.0K
Market Cap
$16.8K

Scopus BioPharma Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Scopus BioPharma Stock Fundamentals & Key Indicators

Check Scopus BioPharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$16.8K

EPS (TTM)

-0.3207

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.98

PEG Ratio

-0.00

Return On Equity TTM

911.69%

Scopus BioPharma stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Scopus BioPharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Scopus BioPharma image
Scopus BioPharma
NA$16.8KNANA0.00%0.00%

Scopus BioPharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-15
-2
-6
-4
-3
-1
-1
-2
-2
EBITDA
-3
-15
-1
-6
-4
-3
-1
-1
-2
-2
Interest Expense
0
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-15
-1
-6
-4
-3
-1
-1
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-15
-1
-6
-4
-3
-1
-1
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Scopus BioPharma Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
0
-2
-10
-27
-11
EBITDA
0
-2
-10
-26
-11
Interest Expense
-
-
0
0
-
Depreciation
0
0
0
0
0
Income Before Tax
0
-2
-10
-26
-11
Income Tax Expense
-
-
0
0
0
Net Income
0
-2
-11
-27
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Scopus BioPharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Net Income
-3
-15
-1
-6
-4
-3
-1
-1
-2
-2
Operating Cash Flow
-2
-1
-2
-4
-3
-2
0
0
0
-1
Investing Cash Flow
-
-
0
-1
0
-
-
-1
-
-
Financing Cash Flow
9
0
0
8
-
-
-
0
2
0
Change in Cash
6
-1
-2
4
-3
-2
0
0
1
-1

Scopus BioPharma Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Net Income
0
-2
-1
-26
-11
Operating Cash Flow
0
-2
-2
-11
-8
Investing Cash Flow
-
0
-
0
0
Financing Cash Flow
0
2
4
17
0
Change in Cash
0
0
1
6
-7

Global Institutional Holdings in Scopus BioPharma

Check out the Institutions with significant holdings in Scopus BioPharma.

Funds
Holdings
UBS Group AG
0.00%
HRT FINANCIAL LLC
0.00%
Y-Intercept (Hong Kong) Ltd
0.00%
M&R Capital Management Inc
0.00%
Northern Trust Corp
0.00%
See all

About Scopus BioPharma

Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer. The company's offerings include the Duet Platform, which incorporates CpG signal transducer and activator of transcription 3 (STAT3) inhibitors. Another significant product is MRI-1867, a cleverly engineered, orally administered, dual-action hybrid small molecule. MRI-1867 functions as an inverse agonist of the endocannabinoid system's cannabinoid receptor 1 (CB1) and additionally acts as an inhibitor of inducible nitric oxide synthase (iNOS). To advance its key development efforts and other programs, Scopus BioPharma has established strategic collaborations with prominent organizations such as the City of Hope, the National Institutes of Health Program, and The Hebrew University of Jerusalem. Established in 2017, the company was originally named Project18 Inc. before officially rebranding to Scopus BioPharma Inc. in December of that year. Its corporate headquarters are located in New York, New York.
OrganisationScopus BioPharma
Headquarters420 Lexington Avenue, New York City, NY, 10170, US
IndustryBiotechnology
CEOAlan D. Horsager

Key Management of Scopus BioPharma

Name

Title

Mr. Ira Scott Greenspan

Senior Advisor & Director

Mr. Robert J. Gibson

Vice Chairman, Secretary & Treasurer

Dr. Alan D. Horsager Ph.D.

President?of?Immuno-Oncology and President & CEO of Duet BioTherapeutics

FAQs

What is Scopus BioPharma share price today?

Scopus BioPharma share price today is $0.00 as on .

What is the 52 week high and 52 week low for Scopus BioPharma share?

Scopus BioPharma share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Scopus BioPharma stock price today i.e. is trending at $0.00,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Scopus BioPharma's market capitalisation today?

Scopus BioPharma market capitalisation is $0.00T as on .

How to invest in Scopus BioPharma Stock (SCPS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Scopus BioPharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Scopus BioPharma Stock (SCPS) from India?

Indian investors can start investing in Scopus BioPharma (SCPS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Scopus BioPharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Scopus BioPharma share’s latest price of $0.00 as on October 15, 2026 at 8:41 pm IST, you will get 25000.0000 shares of Scopus BioPharma. Learn more about fractional shares .